Pharmacy Market

Simcyp™ PBPK for Drug-Drug Interactions (DDI)

July 4, 2023

Simcyp™ PBPK for Drug
The past two decades have witnessed transformative changes in our approach to using modeling & simulation to assess and manage DDIs. Multidisciplinary innovations in mechanistic assessment of absorption, distribution, metabolism, and excretion (ADME), population pharmacology and pharmacogenetics.

Spotlight

The BirgiMefar Group

Pharmaceutical Contract Manufacturer (CMO) of small- and medium- volume parenteral solutions, in ampoules, pre-filled syringes (polypropylene or glass), vials and bottles, as well as sterile solutions in blow-fill-seal (BFS) containers. Mefar offers full service Pharmaceutical CMO services to wide range of local and Fortune 500 Pharmaceutical companies from solution preparation, aseptic filling, packaging to cold-chain management. Mefar has certifications from the Turkish Health Authority, MHRA (the UK), German Health Authority, Romanian Health Authority and Ukrainian Health Authority in sterile product manufacturing.

OTHER WHITEPAPERS
news image

Global Use of Medicines 2023

whitePaper | January 18, 2023

Reaching a post-pandemic era is an alluring prospect for almost everyone around the world after the disruptions of the past three years.

Read More
news image

Winning with biosimilars Opportunities in global markets

whitePaper | March 14, 2022

Over the past several years, biologics have gained significant traction in the pharmaceutical industry, representing more than $150 billion in global sales in 2013. By 2020 they are predicted to generate $290 billion in revenue and comprise 27 percent of the pharmaceutical market.i

Read More
news image

Utilizing Multi-parameter Epitope Binning to Understand aTherapeutic Antibody’s Mechanism of Action

whitePaper | January 20, 2023

Understanding an antibody’s mechanism of action (MOA) is critical to its clinical success. Not only does MOA have a large impact on safety and efficacy.

Read More
news image

How purpose-built tech can help pharmaceutical and life science companies streamline healthcare provider interactions

whitePaper | December 15, 2022

In today’s hypercompetitive pharmaceutical and life sciences (PLS) industry, strategic partnerships are more critical than ever. A smaller life sciences company may have relationships with hundreds of healthcare providers and healthcare organizations.

Read More
news image

Infosys and Top Pharma Bring Digital Transformation to DrugManufacturing Data

whitePaper | April 1, 2022

In 2017, a top 20 global pharmaceutical company began a journey to digitally transform its pharmaceutical engineering and manufacturing capabilities by constructing a data integration and visualization platform, with strategic assistance and technical implementation provided by its partner Infosys.

Read More
news image

Regenerative Medicine

whitePaper | September 16, 2022

T wice a year, we survey the cell and gene therapy landscape and ARM’s initiatives to advance the sector and provide an update to our members.

Read More

Spotlight

The BirgiMefar Group

Pharmaceutical Contract Manufacturer (CMO) of small- and medium- volume parenteral solutions, in ampoules, pre-filled syringes (polypropylene or glass), vials and bottles, as well as sterile solutions in blow-fill-seal (BFS) containers. Mefar offers full service Pharmaceutical CMO services to wide range of local and Fortune 500 Pharmaceutical companies from solution preparation, aseptic filling, packaging to cold-chain management. Mefar has certifications from the Turkish Health Authority, MHRA (the UK), German Health Authority, Romanian Health Authority and Ukrainian Health Authority in sterile product manufacturing.

Events